EXC vs PASG · P/E 17, rev $24.26B vs $25.2M cap
Exelon Corporation (EXC) versus Passage Bio Inc (PASG) — a side-by-side from cached financials, not a winner call.
Exelon Corporation (EXC) is a utilities - regulated electric company listed on NASDAQ.
Passage Bio Inc (PASG) is a biotechnology company listed on US.
Latest reported EXC revenue for 2025-12-31 was $24.26B. Net income was $2.77B. Revenue was up 5.3% from 2024-12-31 to 2025-12-31. EXC currently screens at market cap $47.33B and trailing P/E 16.8.
PASG does not have a complete income-statement cache yet.
EXC currently screens at market cap $47.33B and trailing P/E 16.8. PASG currently screens at market cap $25.2M.
Not investment advice. Open the EXC and PASG stock pages for the full models.
Not investment advice.